David Reubi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
David Reubi has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Anneke C. Hesseling
Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University , Cape Town
2 shared publications - Anthony J. Garcia-Prats
Department of Pediatrics, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA
2 shared publications - Ava E Archey
Univ Virginia, Coll Arts & Sci, Charlottesville, VA USA
2 shared publications - Clare Herrick
Department of Geography King's College London London UK
2 shared publications - Dillon Timothy Wademan
Affiliation Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa
2 shared publications - Graeme Hoddinott
Sydney Infectious Diseases Institute, The University of Sydney , Sydney, New South Wales
2 shared publications
Latest Publications
- Open Access
- 23 November 2025
- Published by BMJ in BMJ Global Health
- Vol. 10 (11) , e019950
Provincialising Global Oncology
- 23 November 2025
- Published by BMJ in BMJ Global Health
- Vol. 10 (11) , e019950
Open AccessProvincialising Global Oncology
- Open Access
- 25 August 2025
- Published by SAGE Publications in Social Studies of Science
- Vol. 56 (3) , 454-483
Cartographic Infrastructures: Geographical Pathology, Tumour Safaris, and Colonial Networks in British East Africa
In this article, we explore infrastructures—human, epistemic, and material—that enable the creation of maps and the stories they tell about the world. We develop the concept of ‘cartographic infrastructures’ to reveal the hidden and fragile political, scientific, and social worlds that undergird the production of maps and the truths they bring into being. To illustrate this, we examine a series of highly influential maps published in the early 1960s by Denis Burkitt—a colonial doctor working in British East Africa—showing the geographical distribution of a pediatric tumour in Africa. By correlating the tumour with altitude and rainfall, the maps suggested it had a viral origin, a finding that profoundly affected cancer research and helped accelerate the development of viral oncology. Using reports, diaries, and photos left behind by Burkitt and others, we excavate the cartographic infrastructures that underpinned his maps and viral hypothesis. First, we examine how the research tradition of geographical pathology—with its focus on environmental factors in carcinogenesis and its interest in Africa as a laboratory for cancer research—provided Burkitt with the theories, networks, and funding necessary to conduct his work. Second, we examine the surveillance practices, ranging from tumour safaris to geographical plotting, that enabled Burkitt to generate and interpret the data underlying his maps. Third, we analyze the communities of white colonial medical officers and missionary doctors spread across Africa with their shared imaginaries of race, empire, and adventure on which Burkitt relied to conduct his surveys.
- 25 August 2025
- Published by SAGE Publications in Social Studies of Science
- Vol. 56 (3) , 454-483
Open AccessCartographic Infrastructures: Geographical Pathology, Tumour Safaris, and Colonial Networks in British East Africa
In this article, we explore infrastructures—human, epistemic, and material—that enable the creation of maps and the stories they tell about the world. We develop the concept of ‘cartographic infrastructures’ to reveal the hidden and fragile political, scientific, and social worlds that undergird the production of maps and the truths they bring into being. To illustrate this, we examine a series of highly influential maps published in the early 1960s by Denis Burkitt—a colonial doctor working in British East Africa—showing the geographical distribution of a pediatric tumour in Africa. By correlating the tumour with altitude and rainfall, the maps suggested it had a viral origin, a finding that profoundly affected cancer research and helped accelerate the development of viral oncology. Using reports, diaries, and photos left behind by Burkitt and others, we excavate the cartographic infrastructures that underpinned his maps and viral hypothesis. First, we examine how the research tradition of geographical pathology—with its focus on environmental factors in carcinogenesis and its interest in Africa as a laboratory for cancer research—provided Burkitt with the theories, networks, and funding necessary to conduct his work. Second, we examine the surveillance practices, ranging from tumour safaris to geographical plotting, that enabled Burkitt to generate and interpret the data underlying his maps. Third, we analyze the communities of white colonial medical officers and missionary doctors spread across Africa with their shared imaginaries of race, empire, and adventure on which Burkitt relied to conduct his surveys.
- Open Access
- 10 December 2024
- Published by SAGE Publications in History of the Human Sciences
The model multiple: Representing cancer in sub-Saharan Africa
Over the past half-century, modelling has come to play an increasingly important role in cancer research. These representational tools frame perceptions of malignant disease, guide public health responses, and help determine which interventions are necessary. But what makes a cancer model a model? What authority do they have? What stories do they tell? And how do they shape our understanding of disease and bodies? To shed light on these questions, this article explores the long history of cancer modelling in sub-Saharan Africa: a place where malignant disease has often been imagined as different, and where experimentation and improvisation in cancer research and treatment has been rife. Drawing on archival and ethnographic sources, we examine modelling strategies that health professionals have used to generate information about cancer in Africa from the mid 20th century to the present day. Focusing on three different case studies – anatomical models of Burkitt's lymphoma patients, diagnostic models for Kaposi sarcoma, and statistical models of the African smoking and lung cancer epidemic – we meditate on the multiplicity of models and modelling by identifying the epistemic strands that hold these representations together, as well as what sets them apart. In addition to contributing to discussions of how cancer research has taken shape beyond the Anglo-American realm, our article helps expand and complicate our understandings of what a disease model is.
- 10 December 2024
- Published by SAGE Publications in History of the Human Sciences
Open AccessThe model multiple: Representing cancer in sub-Saharan Africa
Over the past half-century, modelling has come to play an increasingly important role in cancer research. These representational tools frame perceptions of malignant disease, guide public health responses, and help determine which interventions are necessary. But what makes a cancer model a model? What authority do they have? What stories do they tell? And how do they shape our understanding of disease and bodies? To shed light on these questions, this article explores the long history of cancer modelling in sub-Saharan Africa: a place where malignant disease has often been imagined as different, and where experimentation and improvisation in cancer research and treatment has been rife. Drawing on archival and ethnographic sources, we examine modelling strategies that health professionals have used to generate information about cancer in Africa from the mid 20th century to the present day. Focusing on three different case studies – anatomical models of Burkitt's lymphoma patients, diagnostic models for Kaposi sarcoma, and statistical models of the African smoking and lung cancer epidemic – we meditate on the multiplicity of models and modelling by identifying the epistemic strands that hold these representations together, as well as what sets them apart. In addition to contributing to discussions of how cancer research has taken shape beyond the Anglo-American realm, our article helps expand and complicate our understandings of what a disease model is.
- 15 September 2021
- Published by Elsevier in Health & Place
- Vol. 71, 102672
The future of the global noncommunicable disease agenda after Covid-19
- 15 September 2021
- Published by Elsevier in Health & Place
- Vol. 71, 102672
The future of the global noncommunicable disease agenda after Covid-19
- Open Access
- 11 November 2020
- Published by JMIR Publications Inc. in JMIR mHealth and uHealth
- Vol. 8 (11) , e19154
Opportunities for Mobile App–Based Adherence Support for Children With Tuberculosis in South Africa
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Tuberculosis (TB) is the number one infectious cause of death globally. Young children, generally under the age of five years, are at highest risk of progressing from TB infection to TB disease and of developing the most severe forms of TB. Most current TB drug formulations have poor acceptability among children and require consistent adherence for prolonged periods of time. These challenges complicate children’s adherence to treatment and caregivers’ daily administration of the drugs. Rapid developments in mobile technologies and apps present opportunities for using widely available technology to support national TB programs and patient treatment adherence. Pilot studies have demonstrated that mobile apps are a feasible and acceptable means of enhancing children’s treatment adherence for other chronic conditions. Despite this, no mobile apps have been developed for children that aim to promote adherence to TB treatment. In this paper we draw on our experiences of researching in clinical pediatric TB studies in South Africa. We present hypothetical scenarios of children’s adherence to TB medication to suggest priorities for how a mobile–based app that incorporates behavioral and educational strategies could address some of the adherence support gaps faced by children diagnosed with TB. We argue that a mobile–based app has the potential to lessen some of the negative experiences that children associate with taking TB treatment and to facilitate a more positive treatment adherence experience for children and their caregivers.
- 11 November 2020
- Published by JMIR Publications Inc. in JMIR mHealth and uHealth
- Vol. 8 (11) , e19154
Open AccessOpportunities for Mobile App–Based Adherence Support for Children With Tuberculosis in South Africa
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Tuberculosis (TB) is the number one infectious cause of death globally. Young children, generally under the age of five years, are at highest risk of progressing from TB infection to TB disease and of developing the most severe forms of TB. Most current TB drug formulations have poor acceptability among children and require consistent adherence for prolonged periods of time. These challenges complicate children’s adherence to treatment and caregivers’ daily administration of the drugs. Rapid developments in mobile technologies and apps present opportunities for using widely available technology to support national TB programs and patient treatment adherence. Pilot studies have demonstrated that mobile apps are a feasible and acceptable means of enhancing children’s treatment adherence for other chronic conditions. Despite this, no mobile apps have been developed for children that aim to promote adherence to TB treatment. In this paper we draw on our experiences of researching in clinical pediatric TB studies in South Africa. We present hypothetical scenarios of children’s adherence to TB medication to suggest priorities for how a mobile–based app that incorporates behavioral and educational strategies could address some of the adherence support gaps faced by children diagnosed with TB. We argue that a mobile–based app has the potential to lessen some of the negative experiences that children associate with taking TB treatment and to facilitate a more positive treatment adherence experience for children and their caregivers.
- Open Access
- 18 August 2020
- Published by Wiley in Medical Anthropology Quarterly
- Vol. 34 (3) , 438-455
Epidemiological Imaginaries of the Social: Epidemiologists and Pathologies of Modernization in Postcolonial Africa
There is a growing anthropological literature analyzing the place that epidemiological surveillance occupies in contemporary global health. In this article, I build on this literature and take it into new directions by exploring what I call the epidemiological imaginaries of the social. Drawing on science and technology studies, I suggest that epidemiologists help make up the world, articulating complex and normatively loaded visions of social life that both enable and constrain action. More specifically, I argue that epidemiologists tell stories about the type of societies and people that compose the world and that these stories often shape global health policies and programs in powerful ways. To substantiate this argument, I examine epidemiologists’ efforts to map smoking in postcolonial Africa, documenting how they have imagined smokers and smoking through the lense of modernization theory and showing how these imaginaries have shaped tobacco control policies in the region up to this day.
- 18 August 2020
- Published by Wiley in Medical Anthropology Quarterly
- Vol. 34 (3) , 438-455
Open AccessEpidemiological Imaginaries of the Social: Epidemiologists and Pathologies of Modernization in Postcolonial Africa
There is a growing anthropological literature analyzing the place that epidemiological surveillance occupies in contemporary global health. In this article, I build on this literature and take it into new directions by exploring what I call the epidemiological imaginaries of the social. Drawing on science and technology studies, I suggest that epidemiologists help make up the world, articulating complex and normatively loaded visions of social life that both enable and constrain action. More specifically, I argue that epidemiologists tell stories about the type of societies and people that compose the world and that these stories often shape global health policies and programs in powerful ways. To substantiate this argument, I examine epidemiologists’ efforts to map smoking in postcolonial Africa, documenting how they have imagined smokers and smoking through the lense of modernization theory and showing how these imaginaries have shaped tobacco control policies in the region up to this day.
- Open Access
- 6 April 2020
- Published by JMIR Publications Inc. in JMIR Preprints
Opportunities for Mobile App–Based Adherence Support for Children With Tuberculosis in South Africa (Preprint)
UNSTRUCTURED Tuberculosis is the number one infectious cause of death globally. Young children, generally those younger than 5 years, are at the highest risk of progressing from tuberculosis infection to tuberculosis disease and of developing the most severe forms of tuberculosis. Most current tuberculosis drug formulations have poor acceptability among children and require consistent adherence for prolonged periods of time. These challenges complicate children’s adherence to treatment and caregivers’ daily administration of the drugs. Rapid developments in mobile technologies and apps present opportunities for using widely available technology to support national tuberculosis programs and patient treatment adherence. Pilot studies have demonstrated that mobile apps are a feasible and acceptable means of enhancing children’s treatment adherence for other chronic conditions. Despite this, no mobile apps that aim to promote adherence to tuberculosis treatment have been developed for children. In this paper, we draw on our experiences carrying out research in clinical pediatric tuberculosis studies in South Africa. We present hypothetical scenarios of children’s adherence to tuberculosis medication to suggest priorities for behavioral and educational strategies that a mobile app could incorporate to address some of the adherence support gaps faced by children diagnosed with tuberculosis. We argue that a mobile app has the potential to lessen some of the negative experiences that children associate with taking tuberculosis treatment and to facilitate a more positive treatment adherence experience for children and their caregivers.
- 6 April 2020
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessOpportunities for Mobile App–Based Adherence Support for Children With Tuberculosis in South Africa (Preprint)
UNSTRUCTURED Tuberculosis is the number one infectious cause of death globally. Young children, generally those younger than 5 years, are at the highest risk of progressing from tuberculosis infection to tuberculosis disease and of developing the most severe forms of tuberculosis. Most current tuberculosis drug formulations have poor acceptability among children and require consistent adherence for prolonged periods of time. These challenges complicate children’s adherence to treatment and caregivers’ daily administration of the drugs. Rapid developments in mobile technologies and apps present opportunities for using widely available technology to support national tuberculosis programs and patient treatment adherence. Pilot studies have demonstrated that mobile apps are a feasible and acceptable means of enhancing children’s treatment adherence for other chronic conditions. Despite this, no mobile apps that aim to promote adherence to tuberculosis treatment have been developed for children. In this paper, we draw on our experiences carrying out research in clinical pediatric tuberculosis studies in South Africa. We present hypothetical scenarios of children’s adherence to tuberculosis medication to suggest priorities for behavioral and educational strategies that a mobile app could incorporate to address some of the adherence support gaps faced by children diagnosed with tuberculosis. We argue that a mobile app has the potential to lessen some of the negative experiences that children associate with taking tuberculosis treatment and to facilitate a more positive treatment adherence experience for children and their caregivers.
- Open Access
- 2 January 2018
- Published by Taylor & Francis in Economy and Society
- Vol. 47 (1) , 83-110
Epidemiological accountability: philanthropists, global health and the audit of saving lives
There have been concerns about the recent private turn and re-emergence of philanthropies in world health, with many worrying about philanthropies’ perceived lack of transparency and accountability. In contrast, I argue that while the private turn might have led to a decline in democratic or public accountability, it did not bring an end to all forms of accountability. Specifically, I suggest that philanthropists’ involvement in global health has led to the spread of another, new form of accountability: epidemiological accountability. The latter is a combination of two regimes of expertise and practices hitherto kept separate: audit and epidemiology. To substantiate this argument, I draw on my research on the Bloomberg Initiative – a global effort to reduce tobacco use spearheaded by the Bloomberg and Gates foundations.
- 2 January 2018
- Published by Taylor & Francis in Economy and Society
- Vol. 47 (1) , 83-110
Open AccessEpidemiological accountability: philanthropists, global health and the audit of saving lives
There have been concerns about the recent private turn and re-emergence of philanthropies in world health, with many worrying about philanthropies’ perceived lack of transparency and accountability. In contrast, I argue that while the private turn might have led to a decline in democratic or public accountability, it did not bring an end to all forms of accountability. Specifically, I suggest that philanthropists’ involvement in global health has led to the spread of another, new form of accountability: epidemiological accountability. The latter is a combination of two regimes of expertise and practices hitherto kept separate: audit and epidemiology. To substantiate this argument, I draw on my research on the Bloomberg Initiative – a global effort to reduce tobacco use spearheaded by the Bloomberg and Gates foundations.
- Open Access
- 3 July 2017
- Published by Springer Nature in BioSocieties
- Vol. 13 (1) , 81-102
A genealogy of epidemiological reason: Saving lives, social surveys and global population
Metrics have become all pervasive in global health today. Instead of highlighting their advantages or shortcomings, this article builds on Hacking’s
- 3 July 2017
- Published by Springer Nature in BioSocieties
- Vol. 13 (1) , 81-102
Open AccessA genealogy of epidemiological reason: Saving lives, social surveys and global population
Metrics have become all pervasive in global health today. Instead of highlighting their advantages or shortcomings, this article builds on Hacking’s
- Open Access
- 15 September 2016
- Published by Cambridge University Press (CUP) in Medical History
- Vol. 60 (4) , 453-472
The Internationalisation of Tobacco Control, 1950–2010
This article explores the internationalisation of tobacco control as a case study in the history of international health regulation. Contrary to the existing literature on the topic, it argues that the history of international anti-smoking efforts is longer and richer than the making of the World Health Organisation’s Framework Convention on Tobacco Control in the early twenty-first century. It thereby echoes the point made by other scholars about the importance of history when making sense of contemporary global health. Specifically, the article shows how the internationalisation of tobacco control started in the 1950s through informal contacts between scientists working on cancer research and how these initial interactions were followed by a growing number of more formal initiatives, from the World Conferences on Tobacco or Health to the Bloomberg Initiative to Reduce Tobacco Use. Rather than arranging these efforts in a linear narrative of progress culminating with the Framework Convention on Tobacco Control, we take anthropological claims about global health’s uneven terrain seriously and portray a history of international tobacco control marked by ruptures and discontinuities. Specifically, we identify three successive periods, with each of them characterised by specific understandings of international action, tobacco control expertise, advocacy networks and funding strategies.
- 15 September 2016
- Published by Cambridge University Press (CUP) in Medical History
- Vol. 60 (4) , 453-472
Open AccessThe Internationalisation of Tobacco Control, 1950–2010
This article explores the internationalisation of tobacco control as a case study in the history of international health regulation. Contrary to the existing literature on the topic, it argues that the history of international anti-smoking efforts is longer and richer than the making of the World Health Organisation’s Framework Convention on Tobacco Control in the early twenty-first century. It thereby echoes the point made by other scholars about the importance of history when making sense of contemporary global health. Specifically, the article shows how the internationalisation of tobacco control started in the 1950s through informal contacts between scientists working on cancer research and how these initial interactions were followed by a growing number of more formal initiatives, from the World Conferences on Tobacco or Health to the Bloomberg Initiative to Reduce Tobacco Use. Rather than arranging these efforts in a linear narrative of progress culminating with the Framework Convention on Tobacco Control, we take anthropological claims about global health’s uneven terrain seriously and portray a history of international tobacco control marked by ruptures and discontinuities. Specifically, we identify three successive periods, with each of them characterised by specific understandings of international action, tobacco control expertise, advocacy networks and funding strategies.